Drug Shortage Report for JAMP-ZOLEDRONIC ACID
Report ID | 180271 |
Drug Identification Number | 02482525 |
Brand name | JAMP-ZOLEDRONIC ACID |
Common or Proper name | Zoledronic Acid for Injection |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | ZOLEDRONIC ACID |
Strength(s) | 4MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 5 |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-12-09 |
Estimated end date | 2023-10-15 |
Actual end date | 2023-10-10 |
Shortage status | Resolved |
Updated date | 2023-10-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v26 | 2023-10-18 | French | Compare |
v25 | 2023-10-18 | English | Compare |
v24 | 2023-10-18 | French | Compare |
v23 | 2023-10-18 | English | Compare |
v22 | 2023-09-26 | French | Compare |
v21 | 2023-09-26 | English | Compare |
v20 | 2023-09-11 | French | Compare |
v19 | 2023-09-11 | English | Compare |
v18 | 2023-08-25 | French | Compare |
v17 | 2023-08-25 | English | Compare |
v16 | 2023-08-08 | French | Compare |
v15 | 2023-08-08 | English | Compare |
v14 | 2023-07-17 | French | Compare |
v13 | 2023-07-17 | English | Compare |
v12 | 2023-07-03 | French | Compare |
v11 | 2023-07-03 | English | Compare |
v10 | 2023-06-22 | French | Compare |
v9 | 2023-06-22 | English | Compare |
v8 | 2023-04-12 | French | Compare |
v7 | 2023-04-12 | English | Compare |